A blinded factorial trial protocol proposed measuring benzodiazepine requirements during tetanus care. The paper described planned methods, without reporting an antitoxin-related reduction in sedation.
The planned comparison
Adults with tetanus were to receive different combinations of intrathecal or sham intervention and human or equine intramuscular antitoxin. Mechanical ventilation requirement was the primary outcome.
Total benzodiazepine and pipecuronium doses were among the secondary outcomes. Standard care included benzodiazepines for spasms, with escalation for uncontrolled disease.
Why an endpoint is not a result
The protocol specified continued recording of diazepam doses after ICU discharge until treatment ceased. That makes cumulative exposure a longitudinal endpoint rather than a single admission dose.
This article cannot establish that any antitoxin arm actually reduced benzodiazepine use or improved survival. Dose totals can also reflect disease severity, duration of care, and protocol-driven escalation. When citing the source, describe what the investigators planned to measure and preserve the distinction between background treatment, randomized intervention, and eventual clinical results.
Source paper
Original analysis of the supplied journal article, identified as PMC6372971.
Leave a Reply